Additionally, these data also indicate that activation of Pkcα and its downstream target Fra1 is dependent on Pdgfrβ signaling, and Pdgfrβ signaling is required for maintaining the mesenchymal traits in Brca1-deficient tumor cells. This evidence concerns the gene PRKCA and neoplasm.